01 1Aurobindo Pharma Limited
02 1Fuxin Long Rui Pharmaceutical
03 1Hetero Drugs
04 1JILIN ASYMCHEM LABORATORIES CO LTD
05 1KOLON Life Science, Inc
06 1Kowa India
07 2Lupin Ltd
08 1MSN Laboratories
09 2Nissan Chemical
10 1Solara Active Pharma Sciences
11 1Viatris
12 1Wanbang Biopharmaceuticals
13 1Zhejiang Hisun Pharmaceutical
14 1Zydus Lifesciences
01 1NK-104 TABLETS
02 11PITAVASTATIN CALCIUM
03 1PITAVASTATIN CALCIUM (ASYMMETRIC SYNTHESIS METHOD)
04 1PITAVASTATIN CALCIUM (NON-STERILE DRUG SUBSTANCE)
05 1PITAVASTATIN CALCIUM (PENTAHYDRATE)
06 1PITAVASTATIN SODIUM
01 3China
02 8India
03 2Japan
04 1South Korea
05 2U.S.A
01 13Active
02 3Inactive
01 9Complete
02 7Blank
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-14
Pay. Date : 2013-05-07
DMF Number : 27106
Submission : 2013-05-07
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-22
Pay. Date : 2013-07-10
DMF Number : 27255
Submission : 2013-07-16
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-08-28
Pay. Date : 2013-07-08
DMF Number : 27242
Submission : 2013-07-23
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-05-31
Pay. Date : 2015-11-12
DMF Number : 29650
Submission : 2015-11-06
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-12-17
Pay. Date : 2013-03-28
DMF Number : 23488
Submission : 2010-01-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27761
Submission : 2013-12-10
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14660
Submission : 2000-01-11
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-22
Pay. Date : 2013-07-30
DMF Number : 25956
Submission : 2012-04-11
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-19
Pay. Date : 2013-06-18
DMF Number : 27144
Submission : 2013-06-25
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-22
Pay. Date : 2013-07-29
DMF Number : 27333
Submission : 2013-07-31
Status : Active
Type : II
A Redevant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Redevant, including repackagers and relabelers. The FDA regulates Redevant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Redevant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Redevant manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Redevant supplier is an individual or a company that provides Redevant active pharmaceutical ingredient (API) or Redevant finished formulations upon request. The Redevant suppliers may include Redevant API manufacturers, exporters, distributors and traders.
click here to find a list of Redevant suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Redevant DMF (Drug Master File) is a document detailing the whole manufacturing process of Redevant active pharmaceutical ingredient (API) in detail. Different forms of Redevant DMFs exist exist since differing nations have different regulations, such as Redevant USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Redevant DMF submitted to regulatory agencies in the US is known as a USDMF. Redevant USDMF includes data on Redevant's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Redevant USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Redevant suppliers with USDMF on PharmaCompass.
We have 14 companies offering Redevant
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?